This “anti-cancer weapon” was successfully listed in China this year

In the exhibition area of medical devices and medical care of the third ICIF, a new anti-cancer weapon has arrived as promised this year. Elekta unity, the world’s first high field intensity magnetic resonance radiotherapy system brought by Elekta, is an “old friend” of ICIF. It has participated in the fair for two consecutive years. Since its Asian debut the year before last, the device has been clinically tested and tested in China. This autumn, it was officially approved by the National Drug Administration and successfully listed in China. < / P > < p > on September 20, 2018, with the roar of aircraft, Elekta unity, the world’s first high field intensity MRI radiotherapy system, arrived at Shanghai Pudong airport from Heathrow Airport in the United Kingdom. It is the first exhibit in the medical equipment exhibition hall of the first Import Expo. < / P > < p > in the past, doctors usually make treatment plans and guide radiotherapy according to the CT images before treatment. In fact, due to normal physiological activities such as treatment, disease progression or regression, respiration and digestion, tumor size and location are changing all the time. However, traditional treatment methods can not capture the rapid changes of tumor in real time. The emergence of Elekta unity has solved this long-standing problem of radiotherapy doctors. As a pioneering cancer treatment system, Elekta Unity integrates the physical “water and fire” medical radiotherapy linear accelerator and 1.5T high field magnetic resonance on the same platform, which is the first to realize real-time and high-resolution display and tracking of tumor changes in the process of tumor radiotherapy, so that the radiotherapy doctors can adjust the treatment plan online, carry out “precision guidance” attack on the target tumor, and then achieve real precision Individualized adaptive radiotherapy. < / P > < p > in 2018 and 2019, Elekta unity appeared on the exhibition stand of CIIF for two consecutive years, attracting tens of thousands of medical professionals. Although it did not officially enter China at that time, dozens of large domestic cancer hospitals had come to negotiate purchase agreements. < p > < p > from 2019 to August 2020, Elekta unity carried out strict clinical trials in five hospitals of Chinese Academy of Medical Sciences Cancer Hospital, Shandong Cancer Hospital, Shanghai Fudan Cancer Hospital, Guangzhou Zhongshan cancer hospital and Sichuan cancer hospital for nearly two years, which successfully achieved the indicators of clinical trial scheme design, and finally obtained the approval of the State Drug Administration. According to the introduction of ektec, several clinical trial partners and several domestic cancer hospitals have decided to purchase Elekta unity due to the good clinical trial treatment effect. At present, the General Hospital of the people’s Liberation Army has completed the relevant bidding process and signed the procurement contract with MEDA. Its application in China will fundamentally improve the level of radiotherapy from diagnosis and treatment planning to real-time image-guided radiotherapy. The company was founded in 1972 by Lars Leksell, the founder of gamma knife and the late professor of Neurosurgery at Karolinska Institute in Sweden. The company is headquartered in Stockholm, Sweden. Now, the company has been deeply rooted in China for nearly 40 years. < p > < p > “the fair shows China’s confidence and determination to firmly expand its opening up and inject new impetus into the global economic recovery. MEDA is honored to have participated in the fair for three consecutive years to promote cooperation and exchange in the field of precision radiotherapy in China “China is one of the most important markets of medda in the world,” said Gong Anming, President of MEDTEC China. “We will continue to explore the Chinese market, make full use of the indigenous innovation achievements, enable the intelligent transformation of Chinese radiotherapy field, let more patients return to the road of health, and contribute to the realization of” healthy China 2030 ” Continue ReadingASMC, a lithography maker, was one of TSMC’s 14 top suppliers last year

Author: zmhuaxia